Dynamis Pharmaceuticals, Inc. — Form D
Dynamis Pharmaceuticals, Inc. of JENKINTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-30. The offering totals $458K, of which $458K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-08-30
- Form: D
- Accession: 0001708606-18-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $458K
- Amount sold: $458K
- Minimum investment: $2K
- Investors: 16
- Date of first sale: 2018-08-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320408
Issuer
- Name: Dynamis Pharmaceuticals, Inc.
- CIK: 0001708606
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 261 OLD YORK ROAD, JENKINTOWN, PA, 19046
- Phone: 2153765290
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| David Smith | Director | Saint Louis, MO |
| Annette Tobia | Director | Jenkintown, PA |
| David Smith | Executive Officer | Saint Louis, MO |
| Annette Tobia | Executive Officer | Jenkintown, PA |
Other filings by this issuer (3)
More